Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Erin Schenk

Concepts (195)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
30
2026
2675
3.560
Why?
Carcinoma, Non-Small-Cell Lung
22
2026
1195
3.300
Why?
Platinum
1
2019
48
0.590
Why?
ErbB Receptors
6
2024
636
0.550
Why?
Antineoplastic Combined Chemotherapy Protocols
7
2024
1998
0.530
Why?
Tumor Microenvironment
6
2022
747
0.490
Why?
Neoplasm Staging
6
2026
1488
0.460
Why?
Mutation
6
2024
4093
0.460
Why?
B7-H1 Antigen
3
2026
245
0.440
Why?
Biomarkers, Tumor
9
2026
1339
0.440
Why?
Sarcoma
1
2017
209
0.420
Why?
Protein Kinase Inhibitors
5
2026
983
0.420
Why?
Acrylamides
2
2024
74
0.410
Why?
Aniline Compounds
2
2024
120
0.400
Why?
Proto-Oncogene Proteins p21(ras)
2
2024
250
0.380
Why?
Cytarabine
1
2012
66
0.360
Why?
Immunotherapy
5
2026
671
0.320
Why?
Protein Kinases
1
2012
311
0.320
Why?
Neoplasms
4
2026
2954
0.310
Why?
Neoadjuvant Therapy
2
2024
475
0.280
Why?
Pyrimidines
4
2024
532
0.270
Why?
Cell Cycle Proteins
1
2012
630
0.270
Why?
Humans
39
2026
146342
0.270
Why?
CD3 Complex
1
2026
113
0.230
Why?
Antineoplastic Agents
4
2024
2219
0.230
Why?
Survival Rate
5
2026
2092
0.220
Why?
Leukemia, Myeloid, Acute
1
2012
702
0.220
Why?
Small Cell Lung Carcinoma
1
2026
125
0.210
Why?
Pemetrexed
1
2024
40
0.210
Why?
Zinc Finger Protein Gli2
1
2024
4
0.210
Why?
Antigens, Neoplasm
1
2026
271
0.210
Why?
Cell Line, Tumor
4
2024
3545
0.210
Why?
Proto-Oncogene Proteins c-met
1
2024
76
0.200
Why?
Oncogenes
1
2024
113
0.200
Why?
Neoplasm Proteins
1
2026
444
0.190
Why?
Oncogene Addiction
1
2023
6
0.190
Why?
Practice Guidelines as Topic
3
2026
1591
0.180
Why?
Receptors, Antigen, T-Cell
1
2026
677
0.180
Why?
Bevacizumab
1
2023
169
0.180
Why?
Aged, 80 and over
6
2026
8391
0.170
Why?
Receptors, Purinergic P1
1
2021
30
0.170
Why?
High-Throughput Nucleotide Sequencing
1
2024
539
0.160
Why?
Carcinoma, Pancreatic Ductal
1
2024
297
0.160
Why?
Carbon Monoxide
1
2020
82
0.160
Why?
Major Histocompatibility Complex
1
2021
234
0.160
Why?
Benzimidazoles
1
2021
191
0.160
Why?
Etoposide
2
2019
169
0.150
Why?
Quinazolines
1
2021
267
0.150
Why?
Organophosphorus Compounds
1
2020
84
0.150
Why?
Aged
10
2026
26432
0.150
Why?
Protein-Tyrosine Kinases
1
2023
429
0.150
Why?
Picornaviridae
1
2019
18
0.150
Why?
Proto-Oncogene Proteins
1
2023
616
0.150
Why?
Diagnostic Imaging
1
2022
340
0.150
Why?
Adenosine
1
2021
256
0.150
Why?
Carboplatin
1
2019
168
0.140
Why?
Nuclear Proteins
2
2024
740
0.140
Why?
Histocompatibility Antigens Class II
1
2020
365
0.140
Why?
Cisplatin
2
2019
347
0.140
Why?
Gene Expression Regulation, Neoplastic
1
2024
1432
0.130
Why?
Maximum Tolerated Dose
2
2021
217
0.130
Why?
Middle Aged
11
2026
36619
0.130
Why?
Adaptive Immunity
1
2019
173
0.130
Why?
Trans-Activators
1
2020
372
0.130
Why?
Lymphocyte Count
1
2017
167
0.130
Why?
Antineoplastic Agents, Immunological
1
2019
200
0.120
Why?
Male
13
2026
73396
0.120
Why?
Antigens, CD19
1
2017
137
0.120
Why?
Complement Activation
1
2019
412
0.110
Why?
Pancreatic Neoplasms
1
2024
944
0.110
Why?
Interferon-gamma
1
2019
781
0.110
Why?
Indoles
3
2024
511
0.110
Why?
Female
12
2026
79499
0.110
Why?
ROC Curve
1
2017
617
0.110
Why?
Genomics
1
2020
853
0.110
Why?
Influenza Vaccines
1
2020
544
0.110
Why?
CD8-Positive T-Lymphocytes
1
2021
931
0.110
Why?
Molecular Targeted Therapy
3
2026
447
0.110
Why?
Double-Blind Method
1
2019
2070
0.100
Why?
Monocytes
1
2017
538
0.100
Why?
Drug Resistance, Neoplasm
1
2019
893
0.100
Why?
Dose-Response Relationship, Drug
2
2021
2022
0.100
Why?
Brain Neoplasms
1
2023
1325
0.100
Why?
Bortezomib
1
2013
54
0.100
Why?
Boronic Acids
1
2013
37
0.090
Why?
Immunohistochemistry
3
2022
1712
0.090
Why?
Lactams, Macrocyclic
1
2013
51
0.090
Why?
Benzoquinones
1
2013
46
0.090
Why?
Checkpoint Kinase 1
1
2012
27
0.090
Why?
Ataxia Telangiectasia Mutated Proteins
1
2012
69
0.090
Why?
Pyrazines
1
2013
94
0.090
Why?
Mass Screening
1
2020
1307
0.090
Why?
Cell Cycle Checkpoints
1
2012
97
0.090
Why?
Molecular Chaperones
3
2002
200
0.090
Why?
B7-1 Antigen
2
2008
55
0.090
Why?
Medical Oncology
2
2024
345
0.080
Why?
Prognosis
3
2026
4351
0.080
Why?
Treatment Outcome
3
2026
11821
0.070
Why?
Pyrazoles
1
2012
517
0.070
Why?
Adult
7
2026
41087
0.070
Why?
Mice
7
2026
18297
0.070
Why?
Prospective Studies
1
2020
8123
0.070
Why?
Interleukin-17
1
2008
121
0.070
Why?
Programmed Cell Death 1 Receptor
2
2020
268
0.060
Why?
Forkhead Transcription Factors
1
2008
209
0.060
Why?
Randomized Controlled Trials as Topic
2
2024
1763
0.060
Why?
Neoplasms, Experimental
1
2007
163
0.060
Why?
T-Lymphocytes, Cytotoxic
1
2007
180
0.060
Why?
Antibodies
1
2008
400
0.060
Why?
Immunoglobulin M
1
2007
284
0.060
Why?
Gene Rearrangement
1
2026
156
0.050
Why?
T-Lymphocytes, Regulatory
1
2008
415
0.050
Why?
Flow Cytometry
3
2022
1163
0.050
Why?
Antiporters
2
2002
22
0.050
Why?
T-Lymphocyte Subsets
1
2007
416
0.050
Why?
Cell Proliferation
1
2012
2502
0.050
Why?
Immunoglobulins
2
2002
162
0.050
Why?
Retrospective Studies
4
2024
17438
0.050
Why?
Apoptosis
1
2012
2439
0.050
Why?
DNA Copy Number Variations
1
2024
192
0.050
Why?
Histocompatibility Antigens Class I
2
2002
207
0.050
Why?
Lymphocyte Activation
1
2007
1137
0.050
Why?
Animals
7
2026
38107
0.050
Why?
Carcinogenesis
1
2024
226
0.050
Why?
Autoimmunity
1
2008
925
0.040
Why?
HLA-A Antigens
1
2002
52
0.040
Why?
Neoplasm Metastasis
1
2024
693
0.040
Why?
HLA-B Antigens
1
2002
59
0.040
Why?
Vascular Endothelial Growth Factors
1
2021
77
0.040
Why?
Mitogen-Activated Protein Kinase Kinases
1
2021
126
0.040
Why?
Cell Line
3
2020
2814
0.040
Why?
Cluster Analysis
1
2022
496
0.040
Why?
Central Nervous System
1
2023
278
0.040
Why?
Promoter Regions, Genetic
1
2024
1242
0.040
Why?
Suppressor of Cytokine Signaling 1 Protein
1
2019
12
0.040
Why?
Drug Administration Schedule
1
2021
790
0.040
Why?
Gene Amplification
1
2019
116
0.040
Why?
Polymorphism, Genetic
1
2002
612
0.040
Why?
Chemokine CXCL9
1
2019
38
0.040
Why?
Complement C5a
1
2019
54
0.040
Why?
Complement C3a
1
2019
40
0.040
Why?
Mice, Transgenic
1
2024
2134
0.040
Why?
Disease Models, Animal
2
2020
4580
0.040
Why?
Histones
1
2024
670
0.040
Why?
Gene Silencing
1
2019
200
0.030
Why?
Programmed Cell Death 1 Ligand 2 Protein
2
2008
14
0.030
Why?
Complement Inactivating Agents
1
2019
78
0.030
Why?
Sequence Analysis, RNA
1
2020
441
0.030
Why?
Transcription, Genetic
1
2024
1432
0.030
Why?
Single-Cell Analysis
1
2020
370
0.030
Why?
Disease Progression
1
2024
2867
0.030
Why?
Carcinoma, Small Cell
1
1997
172
0.030
Why?
Ecosystem
1
2020
483
0.030
Why?
Interferon Type I
1
1997
147
0.030
Why?
Carcinoma, Squamous Cell
1
2019
628
0.030
Why?
Antibodies, Monoclonal, Humanized
1
2020
992
0.020
Why?
Macrophages
1
2020
1532
0.020
Why?
T-Lymphocytes
1
2020
2012
0.020
Why?
Membrane Transport Proteins
2
2002
154
0.020
Why?
Magnetic Resonance Imaging
1
2023
3926
0.020
Why?
Follow-Up Studies
1
2019
5439
0.020
Why?
Mice, Inbred C57BL
1
2020
6034
0.020
Why?
T-Cell Antigen Receptor Specificity
1
2008
45
0.020
Why?
Perforin
1
2007
22
0.020
Why?
Pore Forming Cytotoxic Proteins
1
2007
15
0.020
Why?
Cell Communication
1
2008
327
0.010
Why?
Immune Tolerance
1
2008
386
0.010
Why?
Dendritic Cells
1
2008
509
0.010
Why?
Multiple Myeloma
1
2008
310
0.010
Why?
Membrane Glycoproteins
1
2007
495
0.010
Why?
Vaccines
1
2008
389
0.010
Why?
HLA-B15 Antigen
1
2002
12
0.010
Why?
Histidine
1
2002
67
0.010
Why?
Aspartic Acid
1
2002
88
0.010
Why?
Glutamine
1
2002
110
0.010
Why?
Substrate Specificity
1
2002
389
0.010
Why?
CD4-Positive T-Lymphocytes
1
2007
1150
0.010
Why?
Antigen Presentation
1
2002
209
0.010
Why?
Structure-Activity Relationship
1
2002
563
0.010
Why?
Cytokines
1
2008
2081
0.010
Why?
Ligands
1
2002
678
0.010
Why?
Transfection
1
2002
916
0.010
Why?
Blotting, Western
1
2002
1177
0.010
Why?
RNA, Messenger
1
2007
2791
0.010
Why?
Protein Conformation
1
2002
916
0.010
Why?
Amino Acids
1
2002
515
0.010
Why?
Models, Molecular
1
2002
1574
0.010
Why?
Vincristine
1
1997
148
0.010
Why?
Cyclophosphamide
1
1997
275
0.010
Why?
B-Lymphocytes
1
2002
887
0.010
Why?
Peptides
1
2002
992
0.010
Why?
Remission Induction
1
1997
308
0.010
Why?
Protein Binding
1
2002
2244
0.010
Why?
Doxorubicin
1
1997
416
0.010
Why?
Recombinant Proteins
1
1997
1361
0.010
Why?
Schenk's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)